Shimada Hideaki, Fukagawa Takeo, Haga Yoshio, Oba Koji
Department of Surgery Toho University School of Medicine Tokyo Japan.
Gastric Surgery Division National Cancer Center Hospital Tokyo Japan.
Ann Gastroenterol Surg. 2017 Apr 25;1(1):11-23. doi: 10.1002/ags3.12002. eCollection 2017 Apr.
The impact of postoperative complications on survival after radical surgery for esophageal, gastric, and colorectal cancers remains controversial. We conducted a systematic review of recent publications to examine the effect of postoperative complications on oncological outcome.
A literature search of PubMed/MEDLINE was performed using the keywords "esophageal cancer," "gastric cancer," and "colorectal cancer," obtaining 27 reports published online up until the end of April 2016. Articles focusing on (i) postoperative morbidity and oncological outcome; and (ii) body mass index (BMI), postoperative morbidity, and oncological outcome, were selected. Univariate and multivariate analyses (Cox proportional hazards model) were performed.
Patients with postoperative complications had significantly poorer long-term survival than those without complications. Complications were associated with impaired oncological outcomes. The hazard ratios for overall survival were 1.67 (95% confidence interval [CI], 1.31-2.12), 1.59 (95% CI, 1.13-2.24), and 1.55 (95% CI, 1.28-1.87) in esophageal, gastric, and colorectal cancers, respectively. High BMI was associated with postoperative morbidity rate but not with poor oncological outcome. Low BMI was significantly associated with inferior oncological outcome.
Complications after radical surgery for esophageal, gastric, and colorectal cancers are associated with patient prognosis. Avoiding such complications might improve the outcomes.
食管癌、胃癌和结直肠癌根治术后并发症对生存的影响仍存在争议。我们对近期发表的文献进行了系统综述,以研究术后并发症对肿瘤学结局的影响。
使用关键词“食管癌”“胃癌”和“结直肠癌”在PubMed/MEDLINE上进行文献检索,截至2016年4月底共获得27篇在线发表的报告。选取关注以下两方面的文章:(i)术后发病率和肿瘤学结局;(ii)体重指数(BMI)、术后发病率和肿瘤学结局。进行单因素和多因素分析(Cox比例风险模型)。
术后出现并发症的患者长期生存率明显低于未出现并发症的患者。并发症与肿瘤学结局受损相关。食管癌、胃癌和结直肠癌的总生存风险比分别为1.67(95%置信区间[CI],1.31 - 2.12)、1.59(95%CI,1.13 - 2.24)和1.55(95%CI,1.28 - 1.87)。高BMI与术后发病率相关,但与不良肿瘤学结局无关。低BMI与较差的肿瘤学结局显著相关。
食管癌、胃癌和结直肠癌根治术后的并发症与患者预后相关。避免此类并发症可能会改善结局。